Litcius/Paper detail

Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial

Jin Won Youn, Soo Young Hur, Jung Won Woo, Yong‐Man Kim, Myong Cheol Lim, Sangyoon Park, Sang Soo Seo, Jae Hong No, Byoung‐Gie Kim, Jae Kwan Lee, So‐Jin Shin, Kyungun Kim, Marya Chaney, Yoonjeong Choi, You Suk Suh, Jong Sup Park, Young Chul Sung

2020The Lancet Oncology167 citationsDOI

Topics & Concepts

MedicinePembrolizumabInternal medicineCervical cancerOncologyClinical endpointCancerInterim analysisClinical trialImmunotherapyCervical Cancer and HPV ResearchEndometrial and Cervical Cancer TreatmentsImmunotherapy and Immune Responses